Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Milestone Scientific (MLSS) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to 48.07%.

  • Milestone Scientific's EBIT Margin rose 103800.0% to 48.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 75.25%, marking a year-over-year increase of 5500.0%. This contributed to the annual value of 78.8% for FY2024, which is 64800.0% down from last year.
  • Latest data reveals that Milestone Scientific reported EBIT Margin of 48.07% as of Q3 2025, which was up 103800.0% from 64.56% recorded in Q2 2025.
  • Milestone Scientific's 5-year EBIT Margin high stood at 33.66% for Q1 2021, and its period low was 175.01% during Q2 2022.
  • Moreover, its 5-year median value for EBIT Margin was 78.27% (2023), whereas its average is 81.33%.
  • As far as peak fluctuations go, Milestone Scientific's EBIT Margin surged by 17738800bps in 2021, and later crashed by -565900bps in 2022.
  • Over the past 5 years, Milestone Scientific's EBIT Margin (Quarter) stood at 54.89% in 2021, then tumbled by -64bps to 89.9% in 2022, then rose by 3bps to 87.57% in 2023, then dropped by -18bps to 103.57% in 2024, then soared by 54bps to 48.07% in 2025.
  • Its EBIT Margin stands at 48.07% for Q3 2025, versus 64.56% for Q2 2025 and 89.59% for Q1 2025.